NRx Pharmaceuticals Founder Jonathan Javitt Discusses Company’s Mission, Pipeline in Nasdaq Interview December 6, 2023
ATMA Announces Collaboration with Aviva Fohrer to Develop KAT Protocols for Addiction Treatment November 8, 2023
AANA, APNA Issue Joint Statement on Ketamine Infusion Therapy for Psychiatric Disorders November 4, 2023